From CLL to Multiple Myeloma - Spleen Tyrosine Kinase (SYK) influences multiple myeloma cell survival and migration

被引：7
|
作者：
Lorenz, Joschka [1 ]
Waldschmidt, Johannes [1 ]
Wider, Dagmar [1 ]
Follo, Marie [1 ]
Ihorst, Gabriele [2 ]
Chatterjee, Manik [3 ]
May, Annette M. [4 ]
Duyster, Justus [1 ]
Rosenwald, Andreas [5 ]
Waesch, Ralph [1 ]
Zirlik, Katja [1 ]
Engelhardt, Monika [1 ]
机构：
[1] Univ Med Ctr Freiburg, Dept Haematol Oncol & Stem Cell Transplantat, Freiburg, Germany
[2] Univ Med Ctr Freiburg, Clin Trials Ctr, Freiburg, Germany
[3] Univ Hosp Wurzburg, Dept Internal Med 2, Wurzburg, Germany
[4] Univ Freiburg Med Ctr, Inst Pathol, Freiburg, Germany
[5] Univ Hosp Wurzburg, Inst Pathol, Wurzburg, Germany
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2016年 / 174卷 / 06期
关键词：
multiple myeloma; chronic lymphocytic leukemia; spleen tyrosine kinase; R406; therapy; CHRONIC LYMPHOCYTIC-LEUKEMIA; INHIBITION;
D O I：
10.1111/bjh.13825
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：985 / 989
页数：6
相关论文
共 50 条
  • [1] From CLL to multiple myeloma - Spleen Tyrosine Kinase (Syk) influences multiple myeloma cell survival and migration
    Lorenz, J.
    Udi, J.
    Wider, D.
    Waesch, R.
    Zirlik, K.
    Engelhardt, M.
    ONKOLOGIE, 2012, 35 : 140 - 141
  • [2] Syk (spleen tyrosine kinase) regulates proliferation, migration and viability of multiple myeloma cells
    Korber, R-M
    Held, S. A. E.
    Seltmann, N. M.
    Daecke, S.
    von Lilienfeld-Toal, M.
    Bringmann, A.
    Brossart, P.
    ONKOLOGIE, 2010, 33 : 186 - 186
  • [3] Targeting Syk (spleen tyrosine kinase) Inhibits the Proliferation, Migration and Viability of Multiple Myeloma Cells
    Koerber, Ruth-Miriam
    Held, Stefanie A. E.
    Daecke, Solveig
    von Lilienfeld-Toal, Marie
    Bringmann, Anita
    Brossart, Peter
    BLOOD, 2010, 116 (21) : 1658 - 1658
  • [4] BRUTON TYROSINE KINASE EXPRESSION IN MULTIPLE MYELOMA
    Elias, L.
    Buggy, J.
    HAEMATOLOGICA, 2013, 98 : 91 - 91
  • [5] Activity of tyrosine kinase inhibitors in multiple myeloma
    Munker, Reinhold
    Cordova, Cory
    Polk, Paula
    Wendling, Charles V.
    Sun, Amanda W.
    Cardelli, James A.
    BLOOD, 2007, 110 (11) : 274B - 274B
  • [6] Multiple myeloma cell killing by depletion of the MET receptor tyrosine kinase
    Stellrecht, Christine M.
    Phillip, Cornel J.
    Cervantes-Gomez, Fabiola
    Gandhi, Varsha
    CANCER RESEARCH, 2007, 67 (20) : 9913 - 9920
  • [7] Tyrosine Kinase Inhibitors as Antiangiogenic Drugs in Multiple Myeloma
    Ribatti, Domenico
    PHARMACEUTICALS, 2010, 3 (04): : 1225 - 1231
  • [8] Bruton's Tyrosine Kinase Targeting in Multiple Myeloma
    Von Suskil, Max
    Sultana, Kazi Nasrin
    Elbezanti, Weam Othman
    Al-Odat, Omar S.
    Chitren, Robert
    Tiwari, Amit K.
    Challagundla, Kishore B.
    Srivastava, Sandeep Kumar
    Jonnalagadda, Subash C.
    Budak-Alpdogan, Tulin
    Pandey, Manoj K.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2021, 22 (11)
  • [9] Integrin-linked kinase is dispensable for multiple myeloma cell survival
    Steinbrunn, Torsten
    Siegmund, Daniela
    Andrulis, Mindaugas
    Grella, Evelyn
    Kortuem, Martin
    Einsele, Hermann
    Wajant, Harald
    Bargou, Ralf C.
    Stuehmer, Thorsten
    LEUKEMIA RESEARCH, 2012, 36 (09) : 1165 - 1171
  • [10] Expected Survival in Patients with Smoldering Multiple Myeloma and Multiple Myeloma
    Binder, Moritz
    Rajkumar, S. Vincent
    Lakshman, Arjun
    Lacy, Martha Q.
    Gertz, Morie A.
    Buadi, Francis K.
    Dispenzieri, Angela
    Hwa, Lisa
    Fonder, Amie
    Hobbs, Miriam
    Hayman, Suzanne R.
    Zeldenrust, Steven
    Lust, John A.
    Russell, Stephen J.
    Leung, Nelson
    Kapoor, Prashant
    Go, Ronald S.
    Gonsalves, Wilson I.
    Kourelis, Taxiarchis
    Warsame, Rahma
    Kyle, Robert A.
    Kumar, Shaji K.
    BLOOD, 2018, 132
12345